135 related articles for article (PubMed ID: 34343153)
21. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway.
Toloczko A; Guo F; Yuen HF; Wen Q; Wood SA; Ong YS; Chan PY; Shaik AA; Gunaratne J; Dunne MJ; Hong W; Chan SW
Cancer Res; 2017 Sep; 77(18):4921-4933. PubMed ID: 28720576
[TBL] [Abstract][Full Text] [Related]
22. Downstream of human NDR kinases: impacting on c-myc and p21 protein stability to control cell cycle progression.
Cornils H; Kohler RS; Hergovich A; Hemmings BA
Cell Cycle; 2011 Jun; 10(12):1897-904. PubMed ID: 21593588
[TBL] [Abstract][Full Text] [Related]
23. FRK inhibits glioblastoma progression via phosphorylating YAP and inducing its ubiquitylation and degradation by Siah1.
Wang Y; Wang K; Fu J; Zhang Y; Mao Y; Wang X; Wang X; Yu R; Zhou X
Neuro Oncol; 2022 Dec; 24(12):2107-2120. PubMed ID: 35723276
[TBL] [Abstract][Full Text] [Related]
24. Cyclin D1 promotes cell cycle progression through enhancing NDR1/2 kinase activity independent of cyclin-dependent kinase 4.
Du Z; Tong X; Ye X
J Biol Chem; 2013 Sep; 288(37):26678-87. PubMed ID: 23897809
[TBL] [Abstract][Full Text] [Related]
25. Induction of store-operated calcium entry (SOCE) suppresses glioblastoma growth by inhibiting the Hippo pathway transcriptional coactivators YAP/TAZ.
Liu Z; Wei Y; Zhang L; Yee PP; Johnson M; Zhang X; Gulley M; Atkinson JM; Trebak M; Wang HG; Li W
Oncogene; 2019 Jan; 38(1):120-139. PubMed ID: 30082911
[TBL] [Abstract][Full Text] [Related]
26. Angelicin impedes the progression of glioblastoma via inactivation of YAP signaling pathway.
Wang M; Xing S; Jia J; Zeng W; Lei J; Qian Y; Xiong Z; Wang X; Cao L; Wang Y; Wang Y; Jiang Y; Huang Z
Biomed Pharmacother; 2023 May; 161():114462. PubMed ID: 36933380
[TBL] [Abstract][Full Text] [Related]
27. Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP).
Oka T; Mazack V; Sudol M
J Biol Chem; 2008 Oct; 283(41):27534-27546. PubMed ID: 18640976
[TBL] [Abstract][Full Text] [Related]
28. Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway.
Zhao S; Xu K; Jiang R; Li DY; Guo XX; Zhou P; Tang JF; Li LS; Zeng D; Hu L; Ran JH; Li J; Chen DL
Life Sci; 2020 Jun; 251():117424. PubMed ID: 32057900
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of Ca2+-mediated regulation of NDR protein kinase through autophosphorylation and phosphorylation by an upstream kinase.
Tamaskovic R; Bichsel SJ; Rogniaux H; Stegert MR; Hemmings BA
J Biol Chem; 2003 Feb; 278(9):6710-8. PubMed ID: 12493777
[TBL] [Abstract][Full Text] [Related]
30. NDR1 protein kinase promotes IL-17- and TNF-α-mediated inflammation by competitively binding TRAF3.
Ma C; Lin W; Liu Z; Tang W; Gautam R; Li H; Qian Y; Huang H; Wang X
EMBO Rep; 2017 Apr; 18(4):586-602. PubMed ID: 28219902
[TBL] [Abstract][Full Text] [Related]
31. Ablation of the kinase NDR1 predisposes mice to the development of T cell lymphoma.
Cornils H; Stegert MR; Hergovich A; Hynx D; Schmitz D; Dirnhofer S; Hemmings BA
Sci Signal; 2010 Jun; 3(126):ra47. PubMed ID: 20551432
[TBL] [Abstract][Full Text] [Related]
32. Activated Hippo/Yes-Associated Protein Pathway Promotes Cell Proliferation and Anti-apoptosis in Endometrial Stromal Cells of Endometriosis.
Song Y; Fu J; Zhou M; Xiao L; Feng X; Chen H; Huang W
J Clin Endocrinol Metab; 2016 Apr; 101(4):1552-61. PubMed ID: 26977530
[TBL] [Abstract][Full Text] [Related]
33. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
Mana-Capelli S; McCollum D
J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
[TBL] [Abstract][Full Text] [Related]
34. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
35. HIV-1 incorporates and proteolytically processes human NDR1 and NDR2 serine-threonine kinases.
Devroe E; Silver PA; Engelman A
Virology; 2005 Jan; 331(1):181-9. PubMed ID: 15582665
[TBL] [Abstract][Full Text] [Related]
36. The kinases NDR1/2 act downstream of the Hippo homolog MST1 to mediate both egress of thymocytes from the thymus and lymphocyte motility.
Tang F; Gill J; Ficht X; Barthlott T; Cornils H; Schmitz-Rohmer D; Hynx D; Zhou D; Zhang L; Xue G; Grzmil M; Yang Z; Hergovich A; Hollaender GA; Stein JV; Hemmings BA; Matthias P
Sci Signal; 2015 Oct; 8(397):ra100. PubMed ID: 26443704
[TBL] [Abstract][Full Text] [Related]
37. Nuclear Dbf2-related protein kinases (NDRs) in isolated cardiac myocytes and the myocardium: activation by cellular stresses and by phosphoprotein serine-/threonine-phosphatase inhibitors.
Fuller SJ; Pikkarainen S; Tham el L; Cullingford TE; Molkentin JD; Cornils H; Hergovich A; Hemmings BA; Clerk A; Sugden PH
Cell Signal; 2008 Aug; 20(8):1564-77. PubMed ID: 18555663
[TBL] [Abstract][Full Text] [Related]
38. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components.
Kim NG; Koh E; Chen X; Gumbiner BM
Proc Natl Acad Sci U S A; 2011 Jul; 108(29):11930-5. PubMed ID: 21730131
[TBL] [Abstract][Full Text] [Related]
39. FRMD6 inhibits human glioblastoma growth and progression by negatively regulating activity of receptor tyrosine kinases.
Xu Y; Wang K; Yu Q
Oncotarget; 2016 Oct; 7(43):70080-70091. PubMed ID: 27661120
[TBL] [Abstract][Full Text] [Related]
40. cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes.
Kim M; Kim M; Lee S; Kuninaka S; Saya H; Lee H; Lee S; Lim DS
EMBO J; 2013 May; 32(11):1543-55. PubMed ID: 23644383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
